Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.50
+0.28 (1.97%)
At close: Nov 12, 2025, 4:00 PM EST
14.40
-0.10 (-0.69%)
After-hours: Nov 12, 2025, 5:23 PM EST
Embecta Market Cap
Embecta has a market cap or net worth of $848.03 million as of November 12, 2025. Its market cap has increased by 5.73% in one year.
Market Cap
848.03M
Enterprise Value
2.14B
1-Year Change
5.73%
Ranking
Category
Stock Price
$14.50
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $848.03M, a decrease of -68.31%. That is a compound annual growth rate of -27.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 831.66M | -30.72% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 888.22B |
| Johnson & Johnson | 463.86B |
| AbbVie | 396.46B |
| UnitedHealth Group | 293.79B |
| AstraZeneca | 275.02B |
| Novartis AG | 243.29B |
| Merck & Co. | 224.15B |
| Abbott Laboratories | 220.33B |